Teladoc Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Teladoc Health generated cash of $350,021,000, which is more than the previous year. Cash used in financing activities reached the amount of $10,854,000 last year. Net change in cash is therefore $205,493,000.
Cash Flow
| 2014 | -11.35M | -15.57M | 70.16M |
|---|---|---|---|
| 2015 | -47.18M | -108.20M | 164.01M |
| 2016 | -51.79M | 26.14M | 20.59M |
| 2017 | -34.44M | -448.37M | 475.43M |
| 2018 | -4.86M | -257.49M | 645.61M |
| 2019 | 29.86M | 25.01M | 35.09M |
| 2020 | -53.51M | -590.97M | 859.13M |
| 2021 | 193.99M | -72.98M | 40.94M |
| 2022 | 189.29M | -167.74M | 6.49M |
| 2023 | 350.02M | -156.34M | 10.85M |
TDOC Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 918.18M | 893.48M | 733.32M | 514.35M | 423.98M | 42.81M | 50.01M | 55.06M | 46.43M | 3.21M |
Operating activities | ||||||||||
Net income | -220.36M | -13.65B | -428.79M | -485.13M | -98.86M | -97.08M | -106.78M | -74.21M | -58.02M | -17.03M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 351.32M | 270.64M | 219.62M | 78.08M | 44.95M | 35.60M | 19.09M | 8.27M | 4.86M | 2.32M |
Stock-based compensation expense | 201.55M | 217.85M | 302.58M | 475.53M | 66.70M | 0 | 30.59M | 7.72M | 3.07M | 533K |
| Deferred income tax benefit | 201.55M | 217.85M | 302.58M | 475.53M | 66.70M | 0 | 30.59M | 7.72M | 3.07M | 533K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -10.25M | -61.64M | -17.51M | -21.09M | -15.88M | -10.93M | -3.65M | -2.9M | -6.79M | -5.07M |
Inventories | 24.09M | 14.8M | -19.49M | -24.73M | 10.27M | 1.71M | -923K | -2.44M | 4.09M | 2.03M |
Accounts payable | -4.18M | 1.87M | 1.18M | -87.99M | 905K | -391K | 1.53M | -813K | -612K | 2.09M |
Cash generated by operating activities | 350.02M | 189.29M | 193.99M | -53.51M | 29.86M | -4.86M | -34.44M | -51.79M | -47.18M | -11.35M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 63.93M | 26.04M | -5M | -56.34M | -149.26M | -44.14M | -103.03M | 0 |
Investments In Property Plant And Equipment | -156.34M | -172.76M | -63.93M | -26.04M | -10.9M | -8.40M | -5.51M | -3.41M | -7.81M | -1.73M |
Acquisitions Net | 0 | 0 | -78.66M | -567.42M | -11.18M | -282.44M | -379.35M | -37.01M | -17.76M | -13.84M |
Cash generated by investing activities | -156.34M | -167.74M | -72.98M | -590.97M | 25.01M | -257.49M | -448.37M | 26.14M | -108.20M | -15.57M |
Financing activities | ||||||||||
Common Stock Issued | 11.13M | 5.88M | 42.59M | 59.03M | 36.66M | 330.84M | 258.55M | 250K | 163.11M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -278K | 0 | 0 | -26.70M | -1.56M | 0 | 0 | 0 | 0 | -368K |
Repayments of term debt | 0 | 0 | -139K | -238.15M | 0 | 0 | 203.96M | -17.16M | 468K | 0 |
Cash used in financing activities | 10.85M | 6.49M | 40.94M | 859.13M | 35.09M | 645.61M | 475.43M | 20.59M | 164.01M | 70.16M |
Net Change In Cash | 205.49M | 24.70M | 160.15M | 218.97M | 90.36M | 381.17M | -7.19M | -5.05M | 8.63M | 43.22M |
Cash at end of period | 1.12B | 918.18M | 893.48M | 733.32M | 514.35M | 423.98M | 42.81M | 50.01M | 55.06M | 46.43M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |